These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 21277684)

  • 41. Integrated gene expression profile predicts prognosis of breast cancer patients.
    Li LF; Xu XJ; Zhao Y; Liu ZB; Shen ZZ; Jin WR; Shao ZM
    Breast Cancer Res Treat; 2009 Jan; 113(2):231-7. PubMed ID: 18278552
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular profiling assays in breast cancer: are we ready for prime time?
    Gökmen-Polar Y; Badve S
    Oncology (Williston Park); 2012 Apr; 26(4):350-7, 361. PubMed ID: 22655528
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gene expression profiling and clinical outcome in breast cancer.
    Bertucci F; Finetti P; Cervera N; Maraninchi D; Viens P; Birnbaum D
    OMICS; 2006; 10(4):429-43. PubMed ID: 17233555
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical utility of gene-expression signatures in early stage breast cancer.
    Kwa M; Makris A; Esteva FJ
    Nat Rev Clin Oncol; 2017 Oct; 14(10):595-610. PubMed ID: 28561071
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical and therapeutic perspectives of gene expression profiling for breast cancer.
    Chiuri VE; Leo G; Lorusso V
    Ann Oncol; 2007 Jun; 18 Suppl 6():vi58-62. PubMed ID: 17591834
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gene signatures of genomic instability as prognostic tools for breast cancer.
    Sansregret L; Nepveu A
    Future Oncol; 2011 May; 7(5):591-4. PubMed ID: 21568672
    [No Abstract]   [Full Text] [Related]  

  • 47. [Multi-gene assay profiling testing and individualized therapy in breast cancer].
    Chen XS; Shen KW
    Zhonghua Wai Ke Za Zhi; 2017 Feb; 55(2):99-103. PubMed ID: 28162207
    [TBL] [Abstract][Full Text] [Related]  

  • 48. What's new in decoding breast cancer.
    de Snoo F
    Med Princ Pract; 2012; 21(2):99-100. PubMed ID: 22025041
    [No Abstract]   [Full Text] [Related]  

  • 49. Time to move forward from "first-generation" prognostic gene signatures in early breast cancer.
    Desmedt C; Michiels S; Haibe-Kains B; Loi S; Sotiriou C
    Breast Cancer Res Treat; 2011 Aug; 128(3):643-5. PubMed ID: 20953831
    [No Abstract]   [Full Text] [Related]  

  • 50. [Molecular signatures of breast cancer: What clinical utility?].
    Delaloge S; Saghatchian M; Ghouadni A; Fekih M; André F
    Bull Cancer; 2015 Jun; 102(6 Suppl 1):S102-5. PubMed ID: 26118866
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Predicting response to radiotherapy: evolutions and revolutions.
    Begg AC
    Int J Radiat Biol; 2009; 85(10):825-36. PubMed ID: 19863199
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment of pT1N0 breast cancer: multigene predictors to assess risk of relapse.
    Fumagalli D; Sotiriou C
    Ann Oncol; 2010 Oct; 21 Suppl 7():vii103-6. PubMed ID: 20943601
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Omics-based clinical trial designs.
    Buyse M; Michiels S
    Curr Opin Oncol; 2013 May; 25(3):289-95. PubMed ID: 23475192
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gene expression signatures: A tool for analysis of breast cancer prognosis and therapy.
    Latha NR; Rajan A; Nadhan R; Achyutuni S; Sengodan SK; Hemalatha SK; Varghese GR; Thankappan R; Krishnan N; Patra D; Warrier A; Srinivas P
    Crit Rev Oncol Hematol; 2020 Jul; 151():102964. PubMed ID: 32464482
    [TBL] [Abstract][Full Text] [Related]  

  • 55. What should physicians look for in evaluating prognostic gene-expression signatures?
    Subramanian J; Simon R
    Nat Rev Clin Oncol; 2010 Jun; 7(6):327-34. PubMed ID: 20421890
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Re-evaluation of publicly available gene-expression databases using machine-learning yields a maximum prognostic power in breast cancer.
    Tschodu D; Lippoldt J; Gottheil P; Wegscheider AS; Käs JA; Niendorf A
    Sci Rep; 2023 Oct; 13(1):16402. PubMed ID: 37798300
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gene expression profiling of breast cancer.
    Bao T; Davidson NE
    Adv Surg; 2008; 42():249-60. PubMed ID: 18953822
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Gene expression profiling studies in breast cancer].
    Saito H; Miki Y
    Nihon Rinsho; 2012 Sep; 70 Suppl 7():227-31. PubMed ID: 23350397
    [No Abstract]   [Full Text] [Related]  

  • 59. Statistical controversies in clinical research: prognostic gene signatures are not (yet) useful in clinical practice.
    Michiels S; Ternès N; Rotolo F
    Ann Oncol; 2016 Dec; 27(12):2160-2167. PubMed ID: 27634691
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular biology in breast cancer: should molecular classifiers be assessed by conventional tools or by gene expression arrays?
    Fumagalli D; Andre F; Piccart-Gebhart MJ; Sotiriou C; Desmedt C
    Crit Rev Oncol Hematol; 2012 Dec; 84 Suppl 1():e58-69. PubMed ID: 22964299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.